CELON PHARMA S.A. |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 15.7 PLN | +0.64% |
|
+3.56% | +1.55% |
Chart calendar Celon Pharma S.A.
f17019386825be8ba.sNKxHsrkL9TaN5O9l6IvOAsQ9CrDdUprk-8stJBX0O8.5bWJf5uRfLD3Q8vU9vpbaGdDtX36LBJcwroe2uAjv5zGiNlHrZ1Zi69t3g~e4e187fa76f2769aa6c0c05b7ebe7626
Upcoming events on Celon Pharma S.A.
No events available
Past events on Celon Pharma S.A.
| 22/11/2023 | Q3 2023 Earnings Release |
| 20/09/2023 | Q2 2023 Earnings Release |
| 24/05/2023 | Q1 2023 Earnings Release |
| 19/04/2023 | Q4 2022 Earnings Release |
| 23/11/2022 | Q3 2022 Earnings Release |
| 28/09/2022 | Interim 2022 Earnings Release |
| 25/05/2022 | Q1 2022 Earnings Release |
| 27/04/2022 | FY 2021 Earnings Release |
| 29/11/2021 | Q3 2021 Earnings Release |
| 30/09/2021 | Interim 2021 Earnings Release |
| 31/05/2021 | Q1 2021 Earnings Release |
| 21/04/2021 07:30 pm | Capital Markets Day |
| 31/03/2021 | FY 2020 Earnings Release |
| 06/01/2021 | LifeSci Advisors Corporate Access Event |
Past dividends on Celon Pharma S.A.
| 29/06/2023 | Annual 0.09 PLN |
| 30/06/2022 | Annual 0.29 PLN |
| 14/07/2021 | Annual 0.07 PLN |
| 01/06/2020 | Annual 0.08 PLN |
| 29/04/2019 | Annual 0.24 PLN |
| 11/06/2018 | Annual 0.17 PLN |
| 31/05/2017 | Annual 0.17 PLN |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million PLN | Released Forecast Spread | 102 106 -3.17% | 139 135 3.11% | 199 206 -3.47% | 195 194 0.47% | 218 | 255 |
|
EBITDA Million PLN | Released Forecast Spread | 28,4 34,7 -18.07% | 54,8 55,6 -1.47% | 30,9 39,7 -22.13% | 6,76 7,64 -11.53% | 27,4 | 33,8 |
|
EBIT Million PLN | Released Forecast Spread | 6,90 13,2 -47.74% | 23,9 27,8 -14.17% | -10,5 -2,50 -318.12% | -37,3 -38,6 3.36% | -21,8 | -15,9 |
|
Earnings before Tax (EBT) Million PLN | Released Forecast Spread | 7,81 14,1 -44.62% | 22,1 28,0 -21.18% | -15,1 -6,15 -145.32% | -36,4 -39,5 7.72% | -12,6 | -12,3 |
|
Net income Million PLN | Released Forecast Spread | 11,9 13,1 -8.89% | 21,5 26,2 -17.96% | -11,6 -3,33 -248.21% | -39,3 -35,4 -10.97% | -16,2 | -14,1 |
|
EPS PLN | Released Forecast Spread | 0,27 0,00 - | 0,48 0,59 -18.64% | -0,25 -0,20 -25% | -0,77 -0,69 -11.59% | -0,27 | -0,24 |
| Announcement Date | 19/03/20 | 31/03/21 | 02/05/22 | 26/04/23 | - | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million PLN | Released Forecast Spread | 52,9 43,3 22.21% | 41,9 47,0 -10.77% | 52,8 46,6 13.36% | 45,0 45,2 -0.36% | 150 53,3 180.59% | 43,9 50,6 -13.26% | 69,0 53,3 29.36% | 48,8 53,9 -9.39% | 58,2 | 49,0 | 65,5 | 62,5 | 64,3 |
|
EBITDA Million PLN | Released Forecast Spread | 0,55 4,50 -87.76% | 3,14 -0,40 884% | 0,15 -2,55 105.73% | -16,6 4,70 -452.21% | -1,84 1,70 -208.18% | 23,1 6,00 284.95% | 2,99 4,70 -36.47% | 9,30 | 0,30 | 6,90 | 5,80 | 6,40 | |
|
EBIT Million PLN | Released Forecast Spread | -5,99 -1,90 -215.37% | -11,1 -6,50 -70.74% | -8,38 -9,60 12.69% | -11,6 -14,2 18.3% | -25,8 -7,00 -268.23% | -13,6 -9,30 -46.33% | 11,4 -5,70 300.32% | -9,77 -7,40 -32% | -2,35 | -12,3 | |||
|
Earnings before Tax (EBT) Million PLN | Released Forecast Spread | -7,11 -2,30 -209.26% | -8,53 -7,50 -13.72% | -11,4 -16,8 32.14% | -25,0 -15,3 -63.69% | -8,20 | ||||||||
|
Net income Million PLN | Released Forecast Spread | -4,08 -2,10 -94.24% | -7,51 -7,50 -0.16% | -8,11 -10,3 20.88% | -11,7 -13,5 13.56% | -27,6 -6,80 -306% | -9,48 -8,80 -7.67% | 9,14 -4,10 323% | -6,82 -7,80 12.63% | -2,00 | -9,80 | |||
|
EPS PLN | Released Forecast Spread | -0,10 0,00 - | -0,01 -0,10 90% | -0,01 -0,20 95% | ||||||||||
| Announcement Date | 02/05/22 | 25/05/22 | 28/09/22 | 23/11/22 | 26/04/23 | 24/05/23 | 20/09/23 | 22/11/23 | - | - | - | - | - |
More events
Past sector events for Celon Pharma S.A.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- CLN Stock
- Calendar Celon Pharma S.A.